Average Co-Inventor Count = 6.31
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (15 from 1,536 patents)
2. Harvard College (3 from 2,963 patents)
3. Vanderbilt University (1 from 1,153 patents)
18 patents:
1. RE50594 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
2. 12312363 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
3. 12064421 - Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors
4. 12060367 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
5. 12053473 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
6. 11814380 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
7. 10919913 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
8. 10898487 - Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
9. 10882866 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
10. 10829487 - Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors
11. 10717742 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
12. 10576064 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
13. 10508121 - Cortistatin analogues and syntheses and uses thereof
14. 10273241 - Cortistatin analogues and syntheses and uses thereof
15. 10246467 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors